New data indicates that retatrutide, a dual-action medication, may represent a considerable step in size reduction . This drug combines the actions of a GLP-1 agonist and a GIP receptor , potentially https://cruxbookmarks.com/story21719374/a-new-breakthrough-for-weight-regulation